Stock listing
Munich:BHM0 Bachem Holding AG Aktie
German listing (Munich) of Bachem Holding AG · home listing SIX Swiss:BANB
Follow Bachem Holding AG into a list and get an email when it puts out news.
Home listing price · SIX:BANB
76.20 CHF -3.15 (-4.0%)
Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, SIX:BANB
- Day range
- 75.40 – 79.75 CHFNov 20, 2026
- Volume
- 173,479 sharesNov 20, 2026
- Market cap
- 5.71B CHFAt the close on Nov 20, 2026 · price × 74.94M shares outstanding
- 52-week range
- 48.68 – 86.00 CHFLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- 7.24M CHFMedian day 80,671 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| SIX Swiss:BANB · Home | 76.20 CHF | -3.15 (-4.0%) | 173,479 | 79.05 | 79.75 | 75.40 | 79.35 | Close on Nov 20, 2026 |
| LSE:0QND | 76.40 CHF | -3.45 (-4.3%) | 13,740 | 79.60 | 79.60 | 75.60 | 79.85 | Close on Nov 20, 2026 |
| OTC:BCHMY | $9.00 USD | -0.19 (-2.1%) | 100 | $9.00 | $9.00 | $9.00 | $9.19 | Close on Nov 20, 2026 |
| Frankfurt:BHM | €10.22 EUR | +0.082 (+0.8%) | — | €10.22 | €10.22 | €10.22 | €10.14 | Close on Nov 5, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · SIX:BANB · CHF, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| 76.20 | -3.15 | -4.0% | 79.05 | 79.75 | 75.40 | 173,479 | |
| 79.35 | +2.30 | +3.0% | 77.25 | 80.10 | 77.15 | 110,371 | |
| 77.05 | -2.25 | -2.8% | 78.90 | 79.40 | 76.45 | 106,724 | |
| 79.30 | -0.25 | -0.3% | 79.45 | 80.20 | 78.05 | 82,074 | |
| 79.55 | -1.05 | -1.3% | 80.65 | 80.90 | 79.35 | 51,894 | |
| 80.60 | -0.20 | -0.2% | 80.90 | 81.00 | 79.50 | 59,108 | |
| 80.80 | +1.15 | +1.4% | 80.40 | 81.15 | 79.65 | 53,920 | |
| 79.65 | -0.40 | -0.5% | 80.60 | 80.75 | 79.05 | 51,936 | |
| 80.05 | +0.35 | +0.4% | 79.35 | 80.40 | 79.00 | 46,916 | |
| 79.70 | -0.05 | -0.1% | 78.50 | 79.70 | 77.55 | 58,184 | |
| 79.75 | -1.90 | -2.3% | 81.80 | 82.90 | 79.10 | 94,905 | |
| 81.65 | +0.85 | +1.1% | 81.00 | 82.35 | 79.95 | 82,515 | |
| 80.80 | -2.90 | -3.5% | 82.20 | 82.40 | 80.60 | 118,788 | |
| 83.70 | -0.35 | -0.4% | 83.40 | 84.20 | 82.65 | 79,268 | |
| 84.05 | -0.30 | -0.4% | 84.10 | 85.10 | 83.25 | 53,854 | |
| 84.35 | +0.30 | +0.4% | 84.30 | 85.90 | 84.10 | 68,611 | |
| 84.05 | +0.70 | +0.8% | 83.80 | 85.30 | 83.20 | 59,510 | |
| 83.35 | +0.50 | +0.6% | 82.95 | 83.75 | 81.90 | 42,244 | |
| 82.85 | 0.00 | 0.0% | 82.90 | 83.35 | 81.85 | 59,462 | |
| 82.85 | +0.30 | +0.4% | 82.25 | 82.95 | 80.60 | 85,119 | |
| 82.55 | -1.60 | -1.9% | 83.75 | 84.60 | 81.70 | 111,957 | |
| 84.15 | -1.85 | -2.2% | 85.70 | 85.90 | 82.20 | 199,971 | |
| 86.00 | +2.50 | +3.0% | 83.70 | 86.00 | 82.85 | 147,762 | |
| 83.50 | -0.65 | -0.8% | 83.25 | 84.55 | 82.85 | 94,207 | |
| 84.15 | -0.05 | -0.1% | 84.40 | 84.70 | 83.05 | 119,709 | |
| 84.20 | +1.90 | +2.3% | 82.00 | 84.20 | 81.80 | 129,358 | |
| 82.30 | +1.60 | +2.0% | 81.15 | 82.90 | 81.00 | 66,627 | |
| 80.70 | -0.20 | -0.2% | 80.25 | 81.30 | 80.00 | 54,240 | |
| 80.90 | +0.85 | +1.1% | 79.95 | 81.10 | 79.00 | 83,522 | |
| 80.05 | +2.15 | +2.8% | 79.00 | 81.10 | 78.55 | 73,376 | |
| 77.90 | -2.55 | -3.2% | 79.05 | 80.00 | 77.90 | 67,849 | |
| 80.45 | +0.30 | +0.4% | 79.30 | 80.80 | 78.75 | 65,814 | |
| 80.15 | +0.90 | +1.1% | 79.50 | 83.75 | 79.50 | 102,314 | |
| 79.25 | -0.05 | -0.1% | 79.00 | 80.70 | 78.60 | 60,817 | |
| 79.30 | +0.55 | +0.7% | 78.50 | 79.95 | 77.65 | 54,310 | |
| 78.75 | -2.30 | -2.8% | 80.25 | 80.70 | 78.25 | 87,043 | |
| 81.05 | -0.45 | -0.6% | 82.45 | 82.90 | 81.00 | 55,739 | |
| 81.50 | -0.45 | -0.5% | 81.50 | 82.90 | 81.25 | 84,833 | |
| 81.95 | +0.65 | +0.8% | 81.50 | 83.15 | 81.20 | 106,961 | |
| 81.30 | -1.75 | -2.1% | 83.75 | 83.90 | 80.65 | 74,061 | |
| 83.05 | -0.30 | -0.4% | 83.00 | 83.85 | 80.85 | 83,814 | |
| 83.35 | -0.15 | -0.2% | 83.40 | 84.10 | 82.35 | 86,373 | |
| 83.50 | +2.70 | +3.3% | 81.50 | 83.50 | 80.80 | 95,217 | |
| 80.80 | +2.25 | +2.9% | 78.55 | 81.30 | 78.55 | 139,429 | |
| 78.55 | +0.60 | +0.8% | 78.15 | 79.55 | 77.85 | 227,792 | |
| 77.95 | +1.00 | +1.3% | 75.65 | 78.75 | 74.05 | 122,732 | |
| 76.95 | -0.60 | -0.8% | 77.55 | 78.25 | 76.55 | 49,625 | |
| 77.55 | +1.05 | +1.4% | 76.90 | 77.60 | 75.90 | 45,861 | |
| 76.50 | -0.45 | -0.6% | 76.95 | 78.65 | 76.50 | 63,186 | |
| 76.95 | -2.35 | -3.0% | 79.15 | 80.25 | 75.90 | 105,276 | |
| 79.30 | +1.85 | +2.4% | 80.00 | 80.90 | 78.15 | 136,445 | |
| 77.45 | -1.15 | -1.5% | 78.45 | 79.05 | 75.10 | 71,692 | |
| 78.60 | +1.65 | +2.1% | 77.00 | 78.90 | 76.65 | 79,024 | |
| 76.95 | -0.15 | -0.2% | 76.60 | 77.35 | 74.85 | 60,213 | |
| 77.10 | -1.40 | -1.8% | 78.80 | 79.35 | 77.10 | 102,779 | |
| 78.50 | +1.75 | +2.3% | 77.15 | 80.60 | 76.95 | 276,529 | |
| 76.75 | +1.70 | +2.3% | 74.55 | 78.00 | 74.25 | 109,235 | |
| 75.05 | -0.55 | -0.7% | 75.80 | 76.90 | 74.75 | 89,273 | |
| 75.60 | -1.35 | -1.8% | 76.15 | 76.40 | 75.05 | 71,139 | |
| 76.95 | +0.50 | +0.7% | 76.85 | 78.00 | 75.65 | 66,895 | |
| 76.45 | +0.70 | +0.9% | 76.10 | 76.70 | 75.50 | 47,313 | |
| 75.75 | -1.40 | -1.8% | 77.50 | 77.50 | 75.75 | 73,573 | |
| 77.15 | +1.70 | +2.3% | 76.30 | 77.80 | 75.20 | 70,130 | |
| 75.45 | -1.95 | -2.5% | 77.00 | 78.05 | 74.65 | 132,588 | |
| 77.40 | 0.00 | 0.0% | 76.90 | 78.20 | 76.60 | 70,080 | |
| 77.40 | +0.80 | +1.0% | 78.00 | 80.00 | 77.25 | 121,988 |
Splits
2 splits since 2001 · SIX:BANB · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 5-for-1 | Split | |
| 20-for-1 | Split |
- Ticker
- Munich:BHM0
- Asset type
- Stock
- Sector
- Health care
- Industry
- Diagnostics & research services
- Exchange
- Munich
- Currency
- EUR
What changed lately
Latest news release · Jul 30, 2026
Bachem Confirms Growth and Expects a Strong Second Half 2026
Latest earnings call · Jul 30, 2026
Bachem Holding (SIX Swiss: BANB) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Jul 30, 2026
H1 2026 Earnings Presentation
Earnings · 24 slides
Latest news
Bachem Confirms Growth and Expects a Strong Second Half 2026
Jul 30, 2026
Closed 77.00 (+4.6%) on Jul 30, 2026
Bachem Plans to Build a Large-Scale Production Facility in Sisslerfeld
Jul 21, 2026
Closed 77.70 (+10.6%) on Jul 21, 2026
Bachem Holding AG Announces Capital Markets Day 2026
Jun 12, 2026
Closed 66.60 (+0.8%) on Jun 15, 2026
Bachem Announces Changes to the Corporate Executive Committee
May 5, 2026
Closed 75.45 (+2.0%) on May 5, 2026
Bachem Annual General Meeting 2026
Apr 29, 2026
Closed 70.80 (+4.0%) on Apr 30, 2026
Bachem Secures Financing of Strategic Growth Initiatives
Apr 27, 2026
Closed 68.65 (+1.1%) on Apr 27, 2026
Bachem inaugurates Building K in Bubendorf, strengthening large-scale production of modern APIs
Apr 24, 2026
Closed 67.90 (+0.4%) on Apr 24, 2026
Bachem Reports Strong Sales Growth and Sustained High Profitability
Mar 12, 2026
Closed 59.20 (+7.7%) on Mar 12, 2026
Bachem Holding AG on 6ix
- Sector
- Health care
- Industry
- Diagnostics & research services
- News releases
- 10 in the last 12 months · 21 in all · newest Jul 30, 2026 · oldest 2024
- Calls
- 2 calls with a replay · 2 with a transcript · latest Jul 30, 2026
- Decks
- 14 decks · latest Jul 30, 2026
Where Bachem Holding AG is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| SIX Swiss:BANB · Home listing | SIX Swiss | Switzerland | CHF |
| LSE:0QND | LSE | United Kingdom | CHF |
| gettex:BHM0 | gettex | Germany | EUR |
| OTC:BCHMY | OTC | United States | USD |
| OTC:BCHMF | OTC | United States | USD |
| Tradegate:BHM0 | Tradegate | Germany | EUR |
| Aquis:BANBZ | Aquis | United Kingdom | CHF |
| BX Swiss:BANB | BX Swiss | Switzerland | CHF |
| LS Exchange:A3DLKE | LS Exchange | Germany | EUR |
| Frankfurt:BHM | Frankfurt | Germany | EUR |
| Frankfurt:BHM0 | Frankfurt | Germany | EUR |
| Lang & Schwarz:A3DLKE | Lang & Schwarz | Germany | EUR |
| BMV:BANBN | BMV | Mexico | MXN |
| Dusseldorf:BHM0 | Dusseldorf | Germany | EUR |
| Munich:BHM0 · This page | Munich | Germany | EUR |
| Stuttgart:BHM0 | Stuttgart | Germany | EUR |
| Turquoise:BANBZ | Turquoise | United Kingdom | CHF |
| BIVA:BANBN | BIVA | Mexico | MXN |
| Dusseldorf:BHM | Dusseldorf | Germany | EUR |
Valuation
P/E 38.4× against a median of 35.3×: 4th lowest of 7 Diagnostics & research services companies shown. Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- 5.87B CHF
- P/E
- 38.4×
- EV/sales
- 8.4×
- EV/EBITDA
- 29.7×
- Price/book
- 4.0×
- Gross margin
- 28.7%
- Operating margin
- 21.6%
- Net margin
- 21.4%
- Debt to equity
- 0.1×
- Beta
- No index for this market yet
Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Bachem Holding AG Class B · SIX:BANB | US$6.80B | US$6.99B | 38.4× | 8.4× | 29.7× | 4.0× | 21.4% | 0.1× | n/a |
| Bruker Corporation · NASDAQ:BRKR | US$8.62B | US$10.22B | n/a | 2.9× | 64.4× | 3.7× | −3.5% | 0.7× | 1.72 |
| Pharmaron Beijing Co., Ltd. Class A · SZSE:300759 | US$8.54B | US$8.25B | 32.1× | 3.4× | n/a | 3.4× | 11.1% | 0.1× | n/a |
| GenScript Biotech Corporation · HKEX:1548 | US$8.08B | US$7.50B | n/a | 7.8× | 22.8× | 2.1× | −55.5% | 0.1× | n/a |
| Bio-Rad Laboratories, Inc. · NYSE:BIO | US$7.84B | US$7.38B | 7.7× | 2.8× | 71.0× | 1.0× | 39.5% | 0.2× | 0.72 |
| Shenzhen New Industries Biomedical Engineering Co. Ltd. Class A · SZSE:300832 | US$7.53B | US$7.12B | 27.8× | 9.8× | n/a | 5.3× | 37.2% | 0.0× | n/a |
| Twist Bioscience Corporation · NASDAQ:TWST | US$7.04B | US$6.46B | n/a | 14.1× | n/a | 7.9× | −28.3% | 0.0× | 2.77 |
| Asymchem Laboratories (Tianjin) Co., Ltd. Class A · SZSE:002821 | US$6.85B | US$5.90B | 38.5× | 5.3× | n/a | 2.6× | 15.9% | 0.0× | n/a |
| 10x Genomics, Inc. · NASDAQ:TXG | US$6.29B | US$5.79B | n/a | 9.4× | n/a | 7.5× | −10.8% | 0.1× | 2.34 |
| Anthem Biosciences Limited · NSE:ANTHEM | US$5.78B | US$5.71B | 87.3× | 25.9× | 62.5× | 16.3× | 30.0% | 0.0× | n/a |
| Caris Life Sciences, Inc. · NASDAQ:CAI | US$4.97B | US$4.60B | 51.7× | 4.4× | 28.3× | 7.8× | 9.2% | 0.6× | 1.90 |
| Median of the others | US$7.29B | US$6.79B | 35.3× | 6.6× | 62.5× | 4.5× | 10.1% | 0.1× | 1.90 |
Forecasts
Analysts' consensus from EODHD, read Nov 20, 2026. Not 6ix's view and not investment advice.
- Price target
- 84.30 CHF · Analysts' mean
- EPS, year to Dec 2026
- 2.41 · 9 analysts
- Revenue, year to Dec 2026
- 944M · 6 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Anne-Kathrin Stoller | Chief Executive Officer (CEO) |
| Alain Schaffter | Chief Financial Officer (CFO) |
| Hans van Hees | Chief Operations Officer (COO) |
| Barbora Blaha | Head Investor Relations |
| Boris Corpataux | Chief Commercial Officer (CCO) |
| Günther Loidl | Chief Technology Officer (CTO) |
Board
| Director | Role |
|---|---|
| Kuno Sommer | Chairman |
| Nicole Grogg Hötzer | Vice-Chairwoman |
Events
- Next results
- Mar 4, 2027 (expected)
Calls
| Call | When | Status |
|---|---|---|
| Bachem Holding (SIX Swiss: BANB) Q2 2026 Earnings Call | Thu, Jul 30, 2026 · 4:00 AM ET | Replay |
| Bachem Holding (SIX Swiss: BANB) Q4 2025 Earnings Call | Thu, Mar 12, 2026 · 6:00 AM ET | Replay |
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q4 2025 | Dec 31, 2025 | −2.4% |
| Quarter to Sep 30, 2025 | Dec 3, 2025 | +0.5% |
| Q2 2025 | Jul 24, 2025 · After close | −0.7% |
| Quarter to Mar 31, 2025 | May 28, 2025 | +0.6% |
| Q4 2024 | Feb 20, 2025 | +2.1% |
| Quarter to Sep 30, 2024 | Nov 27, 2024 | +0.6% |
| Q2 2024 | Jul 25, 2024 | −8.9% |
| Quarter to Mar 31, 2024 | May 29, 2024 | −2.8% |
| Q4 2023 | Mar 7, 2024 | +16.9% |
| Quarter to Sep 30, 2023 | Nov 29, 2023 | +2.1% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q2 2023 | Jul 27, 2023 · After close | −1.6% |
| Quarter to Mar 31, 2023 | May 31, 2023 | −1.5% |
| Q4 2022 | Mar 7, 2023 · After close | +0.7% |
| Q3 2022 | Nov 30, 2022 | +2.7% |
| Q2 2022 | Aug 25, 2022 · After close | −2.1% |
| Q1 2022 | Jun 1, 2022 | +0.5% |
| Q4 2021 | Mar 18, 2022 · Before open | −9.2% |
| Q3 2021 | Dec 1, 2021 | −5.9% |
| Q2 2021 | Aug 27, 2021 | 0.0% |
| Q1 2021 | Jun 2, 2021 | −0.8% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| H1 2026 Earnings Presentation | Earnings | 24 slides | Jul 30, 2026 |
| FY2025 Earnings Presentation | Earnings | 31 slides | Mar 12, 2026 |
| J.P. Morgan 44th Annual Healthcare Conference 2026 | Conference | 21 slides | Jan 14, 2026 |
| 44th Annual J.P. Morgan Healthcare Conference (January 2026) | Conference | 21 slides | Jan 14, 2026 |
| Investor Day (November 2024) | Investor day | 40 slides | Nov 21, 2024 |
| FY2023 Earnings Presentation | Earnings | 30 slides | Mar 7, 2024 |
| Investor Day (2024) | Investor day | 22 slides | 2024 |
| H1 2023 Earnings Presentation | Earnings | 24 slides | Jul 27, 2023 |
| FY2022 Earnings Presentation | Earnings | 32 slides | Mar 7, 2023 |
| Investor Day (September 2022) | Investor day | 36 slides | Sep 20, 2022 |
All 14 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| FY2021 Earnings Presentation | Earnings | 28 slides | Mar 18, 2022 |
| Investor Presentation (September 2021) | Investor deck | 26 slides | Sep 23, 2021 |
| H1 2021 Earnings Presentation | Earnings | 26 slides | Aug 27, 2021 |
| FY2020 Earnings Presentation | Earnings | 27 slides | Mar 12, 2021 |
Financials
Annual, in CHF
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 695.1M | 605.3M | 577.3M | 531.7M | 503.2M | 402.0M | 313.7M | 282.5M | 261.6M | 236.5M |
| Cost of revenue | 495.3M | 422.7M | 400.4M | 360.5M | 336.5M | 273.1M | 221.2M | 199.3M | 178.9M | 159.2M |
| Gross profit | 199.7M | 182.6M | 177.0M | 171.3M | 166.7M | 128.9M | 92.5M | 83.2M | 82.7M | 77.2M |
| Research and development | 10.2M | 11.4M | 11.0M | 7.20M | 3.82M | 2.94M | 1.66M | 1.76M | 1.97M | 1.56M |
| Selling, general and administrative | 23.3M | 21.8M | 19.4M | 19.0M | 16.9M | 14.6M | 13.6M | 13.9M | 18.0M | 17.6M |
| Operating income | 150.3M | 133.0M | 129.4M | 126.3M | 128.0M | 95.8M | 61.4M | 54.8M | 50.2M | 45.1M |
| Depreciation and amortization | 47.4M | 43.3M | 37.4M | 33.3M | 28.4M | 25.9M | 24.9M | 23.1M | 20.9M | 19.7M |
| EBITDA | 197.7M | 176.3M | 166.7M | 159.6M | 156.5M | 121.7M | 86.3M | 77.9M | 71.1M | 64.8M |
| Interest expense | 484.0K | 292.0K | 367.0K | 719.0K | 798.0K | 591.0K | 495.0K | 614.0K | 441.0K | 347.0K |
| Income before tax | 156.4M | 135.2M | 124.2M | 112.1M | 131.4M | 91.0M | 60.4M | 54.6M | 48.4M | 45.9M |
| Income tax | 7.61M | 15.0M | 12.3M | 11.4M | 16.7M | 12.9M | 6.21M | 7.99M | 6.60M | 4.68M |
| Net income | 148.8M | 120.2M | 111.9M | 100.7M | 114.7M | 78.1M | 54.2M | 46.6M | 41.8M | 41.2M |
| Earnings per share, basic | 1.98 | 1.60 | 1.50 | 1.37 | 1.62 | 1.12 | 0.78 | 0.69 | 0.62 | 0.61 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 31.0M | 95.2M | 157.7M | 31.5M | 89.2M | 23.5M | 21.4M | 22.3M | 17.3M | 19.2M |
| Short-term investments | 0 | 140.8M | 237.0M | 353.2M | ||||||
| Receivables | 188.2M | 273.3M | 200.3M | 179.3M | 114.8M | 80.9M | 87.6M | 85.3M | 58.0M | 52.2M |
| Inventory | 494.4M | 450.2M | 341.0M | 308.0M | 272.4M | 245.2M | 219.2M | 195.6M | 172.7M | 151.9M |
| Current assets | 726.8M | 822.8M | 841.5M | 760.4M | 833.7M | 352.5M | 331.2M | 305.4M | 251.2M | 225.8M |
| Property, plant and equipment | 1.33B | 1.06B | 814.6M | 599.8M | 445.7M | 340.3M | 296.6M | 289.8M | 274.5M | 255.3M |
| Total assets | 2.11B | 1.92B | 1.68B | 1.38B | 1.30B | 710.9M | 647.1M | 614.7M | 544.7M | 496.5M |
| Accounts payable | 41.8M | 72.9M | 29.1M | 32.1M | 25.0M | 25.5M | 18.2M | 9.90M | 17.7M | 19.7M |
| Current liabilities | 405.5M | 281.0M | 164.7M | 164.8M | 134.6M | 137.5M | 104.3M | 194.3M | 136.2M | 99.5M |
| Long-term debt | 0 | 0 | 0 | 60.1M | 60.0M | 284.0K | 188.0K | 302.0K | ||
| Total debt | 57.4M | 290.0K | 401.0K | 691.0K | 20.9M | 107.6M | 107.1M | 150.5M | 94.9M | 55.4M |
| Total liabilities | 650.4M | 531.9M | 362.4M | 214.2M | 177.5M | 235.2M | 199.3M | 230.5M | 170.5M | 131.1M |
| Shareholders' equity | 1.46B | 1.39B | 1.32B | 1.17B | 1.12B | 475.7M | 447.8M | 384.2M | 374.2M | 365.4M |
| Shares outstanding | 75.0M | 75.0M | 74.7M | 73.7M | 70.8M | 70.0M | 69.2M | 67.9M | 67.9M | 67.7M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 271.4M | 146.3M | 249.9M | 92.6M | 97.6M | 115.0M | 64.3M | 25.8M | 36.5M | 40.4M |
| Capital spending | -319.6M | -284.6M | -268.4M | -142.3M | -116.8M | -69.1M | -30.6M | -33.8M | -45.7M | -49.2M |
| Free cash flow | -48.2M | -138.3M | -18.5M | -49.7M | -19.3M | 45.9M | 33.7M | -8.06M | -9.26M | -8.76M |
| Cash from investing | -325.2M | -148.9M | -170.8M | -63.2M | -469.1M | -69.3M | -30.6M | -38.1M | -46.1M | -51.3M |
| Cash from financing | -9.52M | -61.3M | 48.7M | -87.0M | 437.2M | -43.1M | -34.3M | 17.5M | 7.74M | 7.22M |
| Dividends paid | -30.7M | -60.0M | -56.2M | -51.6M | -20.5M | -42.0M | -27.4M | -27.4M | -23.9M | -20.5M |
| Share buybacks | -2.87M | -1.06M | -585.0K | -1.44M | -898.0K | -1.00M | 47.1M | 0 | 52.7M | 17.1M |
| Change in cash | -64.2M | -62.5M | 126.3M | -57.7M | 65.7M | 2.06M | -871.0K | 5.02M | -1.92M | -4.04M |
Cap table
Built by 6ix from Bachem Holding AG Class B’s releases
- Common shares
- 74,935,540
- Fully diluted
- 74,935,540
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 74,935,540 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 74,935,540 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Alain Schaffter | Chief Financial Officer (CFO) · Since at least Jun 12, 2026 |
| Anne-Kathrin Stoller | Chief Executive Officer (CEO) · Since at least Jul 30, 2026 |
| Barbora Blaha | Head Investor Relations · Since at least Jul 30, 2026 |
| Boris Corpataux | Chief Commercial Officer (CCO) · Since at least Jul 30, 2026 |
| Günther Loidl | Chief Technology Officer (CTO) · Since at least Nov 21, 2024 |
| Hans van Hees | Chief Operations Officer (COO) · Since at least Aug 20, 2025 |
| Kuno Sommer | Chairman · Since at least May 5, 2026 |
| Nicole Grogg Hötzer | Vice-Chairwoman · Since at least Apr 29, 2026 |
Log in to ask 6ix AI your own questions about Bachem Holding AG.